Michael John Gill
#163,185
Most Influential Person Now
Researcher
Michael John Gill's AcademicInfluence.com Rankings
Michael John Gillengineering Degrees
Engineering
#7118
World Rank
#8480
Historical Rank
Electrical Engineering
#2193
World Rank
#2299
Historical Rank
Michael John Gillcomputer-science Degrees
Computer Science
#9558
World Rank
#10033
Historical Rank
Computational Linguistics
#2329
World Rank
#2352
Historical Rank
Machine Learning
#4216
World Rank
#4265
Historical Rank
Artificial Intelligence
#4566
World Rank
#4628
Historical Rank
Download Badge
Engineering Computer Science
Michael John Gill's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Michael John Gill Influential?
(Suggest an Edit or Addition)Michael John Gill's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies (2002) (1630)
- Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies (2008) (1310)
- Closing the Gap: Increases in Life Expectancy among Treated HIV-Positive Individuals in the United States and Canada (2013) (1190)
- Effect of early versus deferred antiretroviral therapy for HIV on survival. (2009) (1170)
- Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies (2017) (691)
- Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America. (2012) (475)
- A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. (1996) (286)
- Identification of an Efflux Pump Gene,pmrA, Associated with Fluoroquinolone Resistance inStreptococcus pneumoniae (1999) (271)
- The high cost of medical care for patients who present late (CD4<200 cells/μL) with HIV infection (2004) (263)
- Cumulative Incidence of Cancer Among Persons With HIV in North America: A Cohort Study. (2015) (240)
- Changing mortality rates and causes of death for HIV‐infected individuals living in Southern Alberta, Canada from 1984 to 2003 (2005) (239)
- Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. (2005) (222)
- Late presentation for human immunodeficiency virus care in the United States and Canada. (2010) (215)
- Prevalence of a Putative Efflux Mechanism among Fluoroquinolone-Resistant Clinical Isolates ofStreptococcus pneumoniae (1998) (214)
- Neurologic disease burden in treated HIV/AIDS predicts survival (2010) (206)
- Invasive Cervical Cancer Risk Among HIV-Infected Women: A North American Multicohort Collaboration Prospective Study (2013) (193)
- Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). (2007) (178)
- Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. (2004) (162)
- Predictors of a viral response and subsequent virological treatment failure in patients with HIV starting a protease inhibitor (1998) (152)
- End-stage renal disease among HIV-infected adults in North America. (2015) (151)
- HIV infection of the central nervous system: clinical features and neuropathogenesis. (2008) (144)
- Are There Gender Differences in Starting Protease Inhibitors, HAART, and Disease Progression Despite Equal Access to Care? (2000) (136)
- Sensory neuropathy in human immunodeficiency virus/acquired immunodeficiency syndrome patients: Protease inhibitor–mediated neurotoxicity (2006) (134)
- Gonococcal Resistance to β-Lactams and Tetracycline Involves Mutation in Loop 3 of the Porin Encoded at thepenB Locus (1998) (128)
- Impact of Risk Factors for Specific Causes of Death in the First and Subsequent Years of Antiretroviral Therapy Among HIV-Infected Patients (2014) (123)
- Comparison of Acinetobacter baumannii Isolates from the United Kingdom and the United States That Were Associated with Repatriated Casualties of the Iraq Conflict (2006) (122)
- Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper (1997) (122)
- Virologic and immunologic response to HAART, by age and regimen class (2010) (120)
- Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies (2014) (115)
- Multimorbidity Among Persons Living with Human Immunodeficiency Virus in the United States (2018) (115)
- Incidence of AIDS-Defining Opportunistic Infections in a Multicohort Analysis of HIV-infected Persons in the United States and Canada, 2000-2010. (2016) (114)
- Stability of dried blood spot specimens for detection of human immunodeficiency virus DNA by polymerase chain reaction (1992) (107)
- Neurocognitive screening tools in HIV/AIDS: comparative performance among patients exposed to antiretroviral therapy (2009) (104)
- A Randomized, Double-Blind Trial of Valaciclovir Prophylaxis for Cytomegalovirus Disease in Patients with Advanced Human Immunodeficiency Virus Infection (1998) (104)
- Long-Term Patient Adherence to Antiretroviral Therapy (2000) (98)
- Compartmentalization of the gut viral reservoir in HIV-1 infected patients (2007) (98)
- Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. (2013) (96)
- The NK receptor NKp30 mediates direct fungal recognition and killing and is diminished in NK cells from HIV-infected patients. (2013) (95)
- The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study (2011) (93)
- Accelerated replicative senescence of the peripheral immune system induced by HIV infection (2000) (93)
- Cytotoxic CD4+ T cells use granulysin to kill Cryptococcus neoformans, and activation of this pathway is defective in HIV patients. (2007) (90)
- Changes over time in risk of initial virological failure of combination antiretroviral therapy: a multicohort analysis, 1996 to 2002. (2006) (90)
- Evaluation of brief screening tools for neurocognitive impairment in HIV/AIDS: a systematic review of the literature (2013) (90)
- CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation? (2010) (86)
- Durability of first ART regimen and risk factors for modification, interruption or death in HIV-positive patients starting ART in Europe and North America 2002–2009 (2012) (86)
- Cause-Specific Mortality in HIV-Positive Patients Who Survived Ten Years after Starting Antiretroviral Therapy (2016) (84)
- Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy (2009) (83)
- The effect of reserpine, an inhibitor of multi-drug efflux pumps, on the in-vitro susceptibilities of fluoroquinolone-resistant strains of Streptococcus pneumoniae to norfloxacin. (1997) (81)
- Incidence and risk factors of HPV-related and HPV-unrelated Head and Neck Squamous Cell Carcinoma in HIV-infected individuals. (2014) (79)
- Impact of Age on Retention in Care and Viral Suppression (2015) (78)
- Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies. (2019) (76)
- Reduced glutaraldehyde susceptibility in Mycobacterium chelonae associated with altered cell wall polysaccharides. (1999) (76)
- Dual Therapy Treatment Strategies for the Management of Patients Infected with HIV: A Systematic Review of Current Evidence in ARV-Naive or ARV-Experienced, Virologically Suppressed Patients (2016) (75)
- Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras. (2016) (74)
- How Generalizable Are the Results From Trials of Direct Antiviral Agents to People Coinfected With HIV/HCV in the Real World? (2016) (72)
- Domestic violence screening: prevalence and outcomes in a Canadian HIV population. (2010) (72)
- The Direct Medical Costs of Late Presentation (<350/mm3) of HIV Infection over a 15-Year Period (2011) (70)
- Cohort profile: Antiretroviral Therapy Cohort Collaboration (ART-CC). (2014) (68)
- Expression of Ley antigen in human immunodeficiency virus-infected human T cell lines and in peripheral lymphocytes of patients with acquired immune deficiency syndrome (AIDS) and AIDS-related complex (ARC) (1988) (67)
- The changing direct costs of medical care for patients with HIV/AIDS, 1995-2001. (2003) (66)
- Emergence of atovaquone-proguanil resistance during treatment of Plasmodium falciparum malaria acquired by a non-immune north American traveller to west Africa. (2005) (65)
- HIV Infection, Immunosuppression, and Age at Diagnosis of Non-AIDS-Defining Cancers (2016) (65)
- NeuroAIDS: An Evolving Epidemic (2009) (65)
- Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for Determination of HIV-1 Viral Loads in a Cohort of Canadian Patients with Diverse HIV Subtype Infections (2010) (65)
- The Clinical Implications of High Rates of Intimate Partner Violence Against HIV-Positive Women (2013) (64)
- Cost of medical care for HIV‐infected patients within a regional population from 1997 to 2006 (2008) (64)
- Trends in multidrug treatment failure and subsequent mortality among antiretroviral therapy-experienced patients with HIV infection in North America. (2009) (64)
- Predictors of symptomatic HIV‐associated neurocognitive disorders in universal health care (2013) (63)
- Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV. (2003) (62)
- Disparities in the quality of HIV care when using US Department of Health and Human Services indicators. (2014) (62)
- Patients presenting with AIDS in the HAART era: a collaborative cohort analysis (2008) (62)
- CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus–Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC) (2017) (61)
- Hepatitis C virus co-infection increases neurocognitive impairment severity and risk of death in treated HIV/AIDS (2012) (60)
- Cancer-Attributable Mortality Among People With Treated Human Immunodeficiency Virus Infection in North America (2017) (59)
- Longitudinal assessment (1995–2003) of hospitalizations of HIV‐infected patients within a geographical population in Canada (2006) (59)
- Saccharomyces cerevisiae fungemia: case report and review of the literature. (1987) (56)
- The effect of injecting drug use history on disease progression and death among HIV‐positive individuals initiating combination antiretroviral therapy: collaborative cohort analysis (2012) (56)
- Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study (2016) (55)
- Prevalence, clinical associations, and impact of intimate partner violence among HIV‐infected gay and bisexual men: a population‐based study (2013) (54)
- Activity of the soft gelatin formulation of saquinavir in combination therapy in antiretroviral‐naive patients (1998) (54)
- Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain (2017) (53)
- Neurologic immune reconstitution inflammatory syndrome in HIV/AIDS (2009) (53)
- Gene transfer, gentamicin resistance and enterococci. (1997) (53)
- Intimate Partner Violence and HIV: A Review (2013) (53)
- "Campylobacter cinaedi" bacteremia: case report and laboratory findings (1987) (52)
- Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study (2016) (51)
- Hepatitis C viremia and the risk of chronic kidney disease in HIV-infected individuals. (2013) (50)
- Evidence for efflux pumps, other than PmrA, associated with fluoroquinolone resistance in Streptococcus pneumoniae. (2003) (50)
- HIV-1 viral diversity and its implications for viral load testing: review of current platforms. (2011) (49)
- Pill Burden in HIV Infection: 20 Years of Experience (2012) (49)
- Efficacy of commercial condoms in the prevention of hepatitis B virus infection. (1987) (49)
- A community randomized controlled clinical trial of mixed carotenoids and micronutrient supplementation of patients with acquired immunodeficiency syndrome (2006) (49)
- HPV DNA Typing of adult‐onset respiratory papillomatosis (1990) (48)
- First Occurrence of Diabetes, Chronic Kidney Disease, and Hypertension Among North American HIV-Infected Adults, 2000–2013 (2016) (47)
- Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients. (2014) (45)
- Functional characterization of a sialyltransferase-deficient mutant of Neisseria gonorrhoeae (1996) (45)
- HIV-Related Neurological Syndromes Reduce Health-Related Quality of Life (2005) (45)
- Unappreciated epidemiology: the churn effect in a regional HIV care programme (2009) (45)
- Active immunization of patients with HIV infection: a study of the effect of VaxSyn, a recombinant HIV envelope subunit vaccine, on progression of immunodeficiency. (1998) (43)
- Rhodococcus equi--an easily missed opportunistic pathogen. (1991) (42)
- Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV‐1 positive patients with well‐estimated dates of seroconversion (2017) (42)
- Mechanisms of resistance to the carbapenems. (1995) (41)
- External Quality Assessment of HLA-B*5701 Reporting: An International Multicentre Survey (2007) (41)
- Potential for underdosing and emergence of resistance in Acinetobacter baumannii during treatment with colistin. (2008) (40)
- Association of immunosuppression and HIV viraemia with non-Hodgkin lymphoma risk overall and by subtype in people living with HIV in Canada and the USA: a multicentre cohort study. (2019) (39)
- HIV dementia patients exhibit reduced viral neutralization and increased envelope sequence diversity in blood and brain (2002) (39)
- Inflammation and epithelial cell injury in AIDS enteropathy: involvement of endoplasmic reticulum stress (2011) (39)
- Increased costs of HIV care associated with aging in an HIV‐infected population (2015) (38)
- Plasma microRNA profiling predicts HIV-associated neurocognitive disorder (2016) (38)
- Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration (2015) (38)
- Emergence of a fluoroquinolone-resistant strain of Streptococcus pneumoniae in England. (2003) (38)
- Risk factors for tuberculosis after highly active antiretroviral therapy initiation in the United States and Canada: implications for tuberculosis screening. (2011) (38)
- Serotyping Neisseria gonorrhoeae: a report of the Fourth International Workshop. (1991) (37)
- Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics. (2012) (37)
- Successful Discontinuation of Therapy for Disseminated Mycobacterium avium Complex Infection after Effective Antiretroviral Therapy (2002) (36)
- Plasmid heterogeneity and identification of a Tn5281-like element in clinical isolates of high-level gentamicin-resistant Enterococcus faecium isolated in the UK. (1999) (36)
- Herpes simplex virus infection of the hand: A profile of 79 cases (1988) (36)
- Detection of the tetM Determinant in Neisseria gonorrhoeae (1991) (36)
- HIV and Other Lentiviral Infections Cause Defects in Neutrophil Chemotaxis, Recruitment, and Cell Structure: Immunorestorative Effects of Granulocyte-Macrophage Colony-Stimulating Factor1 (2006) (35)
- TETRACYCLINE-RESISTANT GONOCOCCI IN UK (1988) (35)
- Using observational data to emulate a randomized trial of dynamic treatment-switching strategies: an application to antiretroviral therapy. (2016) (35)
- Cervical cancer risk in women living with HIV across four continents: A multicohort study (2020) (34)
- Outer-membrane proteins pattern and detection of beta-lactamases in clinical isolates of imipenem-resistant Acinetobacter baumannii from Brazil. (2000) (34)
- Comparison of Kaposi Sarcoma Risk in Human Immunodeficiency Virus-Positive Adults Across 5 Continents: A Multiregional Multicohort Study (2017) (33)
- The five-year impact of an evolving global epidemic, changing migration patterns, and policy changes in a regional Canadian HIV population. (2009) (32)
- Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients. (2013) (32)
- Increased non‐AIDS mortality among persons with AIDS‐defining events after antiretroviral therapy initiation (2018) (31)
- Late Expression of Granulysin by Microbicidal CD4+ T Cells Requires PI3K- and STAT5-Dependent Expression of IL-2Rβ That Is Defective in HIV-Infected Patients1 (2008) (31)
- Influence of geographical origin and ethnicity on mortality in patients on antiretroviral therapy in Canada, Europe, and the United States. (2013) (31)
- Role of viral evolutionary rate in HIV-1 disease progression in a linked cohort (2005) (31)
- Avascular necrosis in HIV infection. (1999) (31)
- Risk of Incident Diabetes Mellitus, Weight Gain, and their Relationships with Integrase Inhibitor-based Initial Antiretroviral Therapy Among Persons with HIV in the US and Canada. (2020) (31)
- Herpes simplex virus infection of the hand. (1990) (30)
- Gastrointestinal tissue cultures for HIV in HIV‐infected/AIDS patients (1992) (29)
- HIV-associated non-Hodgkin's lymphoma of the gastrointestinal tract. (1996) (29)
- The Impact of Non-Antiretroviral Polypharmacy on the Continuity of Antiretroviral Therapy (ART) Among HIV Patients. (2016) (29)
- Purification and characterization of the reovirus cell attachment protein σ1 (1987) (28)
- Antiretroviral medication adherence and persistence with respect to adherence tool usage. (2000) (28)
- Impact of current antiretroviral therapies on neuroAIDS (2011) (27)
- A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group. (1998) (27)
- Uptake of combination antiretroviral therapy and HIV disease progression according to geographical origin in seroconverters in Europe, Canada, and Australia. (2012) (27)
- Comparative Effectiveness of Initial Antiretroviral Therapy Regimens: ACTG 5095 and 5142 Clinical Trials Relative to ART-CC Cohort Study (2011) (26)
- Successful implementation of a national HLA-B*5701 genetic testing service in Canada. (2010) (26)
- Nature of transposon-mediated high-level gentamicin resistance in Enterococcus faecalis isolated in the United Kingdom. (2000) (26)
- Neurocognitive Symptoms and Impairment in an HIV Community Clinic (2001) (25)
- HIV-associated sensory polyneuropathy and neuronal injury are associated with miRNA-455-3p induction. (2018) (25)
- Virological characteristics of occult hepatitis B virus in a North American cohort of human immunodeficiency virus type 1-positive patients on dual active anti-HBV/HIV therapy. (2014) (25)
- Increasing HIV subtype diversity and its clinical implications in a sentinel North American population. (2013) (25)
- Peptides in the gastrointestinal tract in human immunodeficiency virus infection. The GI/HIV Study Group of the University of Calgary. (1992) (25)
- Topical undecylenic acid for herpes simplex labialis: a multicenter, placebo-controlled trial. (1997) (25)
- Erratic zidovudine bioavailability in HIV seropositive patients. (1993) (25)
- Neuropsychiatric disorders in HIV infection: impact of diagnosis on economic costs of care (2006) (25)
- The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS‐defining cancers in Southern Alberta (2006) (24)
- Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group. (1998) (23)
- Risk of End‐Stage Renal Disease in HIV‐Positive Potential Live Kidney Donors (2017) (23)
- Life-Expectancy Disparities Among Adults With HIV in the United States and Canada: The Impact of a Reduction in Drug- and Alcohol-Related Deaths Using the Lives Saved Simulation Model (2019) (23)
- Outpatient parenteral antibiotic therapy: evolution of the Calgary adult home parenteral therapy program. (2002) (23)
- Herpes simplex virus infection of the hand. A profile of 79 cases. (1988) (22)
- Higher levels of Zidovudine resistant HIV in the colon compared to blood and other gastrointestinal compartments in HIV infection (2010) (22)
- Penicillin and cephalosporin resistance in gonococci. (1990) (22)
- Evaluating the Impact of Functional Genetic Variation on HIV-1 Control (2017) (22)
- Human orf. A diagnostic consideration? (1990) (22)
- Randomized, Double-Blind, Placebo-Controlled, Clinic-Initiated, Canadian Multicenter Trial of Topical Edoxudine 3.0% Cream in the Treatment of Recurrent Genital Herpes (1991) (22)
- Gastrointestinal symptoms in ambulatory HIV-infected patients (1993) (21)
- Survival Outcomes and Effect of Early vs. Deferred cART Among HIV-Infected Patients Diagnosed at the Time of an AIDS-Defining Event: A Cohort Analysis (2011) (21)
- Short communication: identification of a novel HIV type 1 subtype H/J recombinant in Canada with discordant HIV viral load (RNA) values in three different commercial assays. (2007) (21)
- Implementing an intimate partner violence (IPV) screening protocol in HIV care. (2015) (20)
- Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice? (2008) (20)
- Associations between Depressive Symptomatology and Neurocognitive Impairment in HIV/AIDS (2018) (20)
- Human orf. A diagnostic consideration (1990) (20)
- Neurotoxicity of acyclovir in end stage renal disease. (1990) (20)
- Lifetime antiretroviral exposure and neurocognitive impairment in HIV (2020) (19)
- Characterizing the HIV epidemic in the prairie provinces. (2012) (19)
- Absence of an Association Between Enteric Parasites in the Manifestations and Pathogenesis of HIV Enteropathy in Gay Men (1992) (18)
- Association of immunosuppression and HIV viremia with anal cancer risk in persons living with HIV in the United States and Canada. (2019) (18)
- Naturally occurring PIA/PIB hybrids of Neisseria gonorrhoeae. (1994) (18)
- A multidrug efflux phenotype mutant of Streptococcus pyogenes. (2003) (18)
- A potentially preventable case of serious influenza infection in a pregnant patient (2007) (18)
- Therapy for recurrent herpetic whitlow. (1986) (18)
- A Flow-Based Model of the HIV Care Continuum in the United States (2017) (18)
- The impact on health-related quality of life of treatment interruptions in HIV-1-infected patients. (2003) (18)
- Decision making under explicit risk is impaired in individuals with human immunodeficiency virus (HIV) (2015) (17)
- Increasing incidence of syphilis among patients engaged in HIV care in Alberta, Canada: a retrospective clinic-based cohort study (2018) (17)
- Late presentation of Cryptococcus gattii meningitis in a traveller to Vancouver Island: A case report. (2007) (17)
- Machine learning models reveal neurocognitive impairment type and prevalence are associated with distinct variables in HIV/AIDS (2019) (17)
- Sex‐based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA) (2018) (17)
- Gastrointestinal function and structure in HIV-positive patients. (1990) (16)
- The Effect of Churn on “Community Viral Load” in a Well-Defined Regional Population (2013) (16)
- Effect of Immediate Initiation of Antiretroviral Treatment in HIV-Positive Individuals Aged 50 Years or Older (2017) (16)
- Pharmacokinetics and metabolism of E-5-(2-[131I]iodovinyl)-2'-deoxyuridine in dogs (1986) (16)
- Randomised, Multicentre Phase III Study of Saquinavir plus Zidovudine plus Zalcitabine in Previously Untreated or Minimally Pretreated HIV-Infected Patients (2000) (16)
- Trends in Hepatocellular Carcinoma Incidence and Risk Among Persons With HIV in the US and Canada, 1996-2015 (2021) (16)
- Combating the HIV reservoirs (2018) (16)
- High Mortality Among Human Immunodeficiency Virus (HIV)-Infected Individuals Before Accessing or Linking to HIV Care: A Missing Outcome in the Cascade of Care? (2014) (16)
- A retrospective study of the clinical features of new syphilis infections in an HIV-positive cohort in Alberta, Canada (2018) (15)
- An approach to conference selection and evaluation: advice to avoid “predatory” conferences (2018) (15)
- Adverse Health Effects for Individuals Who Move Between HIV Care Centers (2011) (15)
- Risk of HCC With Hepatitis B Viremia Among HIV/HBV‐Coinfected Persons in North America (2021) (15)
- Childhood lymphadenitis in a harsh northern climate due to atypical mycobacteria. (1987) (15)
- De‐simplifying single‐tablet antiretroviral treatments: uptake, risks and cost savings (2019) (15)
- Detection of Hepatitis B Virus (HBV) Genomes and HBV Drug Resistant Variants by Deep Sequencing Analysis of HBV Genomes in Immune Cell Subsets of HBV Mono-Infected and/or Human Immunodeficiency Virus Type-1 (HIV-1) and HBV Co-Infected Individuals (2015) (15)
- Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS (2010) (15)
- Discrepancies in assignment of subtype/recombinant forms by genotyping programs for HIV type 1 drug resistance testing may falsely predict superinfection. (2008) (14)
- Oral acyclovir therapy of recurrent herpes simplex virus type 2 infection of the hand (1991) (14)
- Surveillance of Infection Severity: A Registry Study of Laboratory Diagnosed Clostridium difficile (2012) (14)
- A population with short delay from diagnosis of human immunodeficiency virus to medical care. (1999) (14)
- Evidence for host-driven selection of the HIV type 1 vpr gene in vivo during HIV disease progression in a transfusion-acquired cohort. (2005) (14)
- Tobacco Smoking Is Not Associated With Accelerated Liver Disease in Human Immunodeficiency Virus-Hepatitis C Coinfection: A Longitudinal Cohort Analysis (2016) (14)
- Heterophilic interference in specimens yielding false-reactive results on the Abbott 4th generation ARCHITECT HIV Ag/Ab Combo assay. (2018) (14)
- HIV misdiagnosis: A root cause analysis leading to improvements in HIV diagnosis and patient care. (2017) (14)
- Brief Report: Cutaneous Melanoma Risk Among People With HIV in the United States and Canada (2018) (13)
- Cytomegalovirus disease in HIV infection: twenty years of a regional population's experience. (2006) (13)
- Comorbidities in Older Persons with Controlled HIV Infection: Correlations with Frailty Index Subtypes. (2020) (13)
- An avoidable transmission of HIV from mother to child (2011) (13)
- Micronutrient Deficiency and Treatment Adherence in a Randomized Controlled Trial of Micronutrient Supplementation in ART-Naïve Persons with HIV (2014) (13)
- Prognosis of HIV-1 infected drug naïve patients starting potent antiretroviral therapy. ART Cohort Collaboration (2002) (12)
- Improved Survival and Reduced Clinical Progression in HIV-Infected Patients with Advanced Disease Treated with Saquinavir plus Zalcitabine (1998) (12)
- Missing data on the estimation of the prevalence of accumulated human immunodeficiency virus drug resistance in patients treated with antiretroviral drugs in north america. (2011) (12)
- Empiric neurocognitive performance profile discovery and interpretation in HIV infection (2018) (12)
- Phenotypic variations and switches in HIV isolated from the blood and the gastrointestinal tissues of patients with HIV‐1 infection (1997) (11)
- One Size Fits (n)One: The Influence of Sex, Age, and Sexual Human Immunodeficiency Virus (HIV) Acquisition Risk on Racial/Ethnic Disparities in the HIV Care Continuum in the United States (2018) (11)
- Montreal Cognitive Assessment Performance in HIV/AIDS: Impact of Systemic Factors (2015) (11)
- The Cost of Antiretroviral Drug Resistance in HIV-Positive Patients (2014) (11)
- Full-length HIV type 1 genome analysis showing evidence for HIV type 1 transmission from a nonprogressor to two recipients who progressed to AIDS. (2005) (11)
- Quantitative uptake studies of 131I-labeled (E)-5-(2-iodovinyl)-2'-deoxyuridine in herpes simplex virus-infected cells in vitro (1984) (11)
- Lentiviral Infections Persist in Brain despite Effective Antiretroviral Therapy and Neuroimmune Activation (2021) (11)
- Encephalopathy with Staphylococcal Endocarditis: Multiple Neuropathological Findings (2001) (10)
- Impact of Practice Changes on an Antiretroviral Budget in an HIV Care Program (2005) (10)
- Lymphocyte membrane modifications induced by HIV infection. (1994) (10)
- Evaluation of A Phylogenetic Pipeline to Examine Transmission Networks in A Canadian HIV Cohort (2020) (10)
- Comparison of healthcare costs between local and immigrant HIV populations living in Southern Alberta, Canada. (2011) (10)
- Managing HIV infection in patients older than 50 years (2018) (10)
- Multimorbidity Among Persons Living with HIV in the U.S. (2017) (10)
- Reduced Cancer Survival Among Adults With HIV and AIDS-Defining Illnesses Despite No Difference in Cancer Stage at Diagnosis (2018) (10)
- Hospitalization Rates and Causes among Persons with HIV in the US and Canada, 2005-2015. (2020) (9)
- Cumulative Incidence of Cancer among HIV-infected Individuals in North America (2016) (9)
- Hospitalization Rates and Causes among Persons with HIV in the US and Canada, 2005-2015. (2020) (9)
- Z-FA-FMK as a novel potent inhibitor of reovirus pathogenesis and oncolysis in vivo (2010) (9)
- Mechanisms by Which Interleukin-12 Corrects Defective NK Cell Anticryptococcal Activity in HIV-Infected Patients (2016) (9)
- Determinants of Risk-Taking in HIV-Associated Neurocognitive Disorders (2017) (9)
- Hypoglycemic coma, jaundice, and pure RBC aplasia following chlorpropamide therapy. (1980) (9)
- Hepatitis C virus cure does not impact kidney function decline in HIV co-infected patients (2018) (9)
- CD 4 : CD 8 Ratio and CD 8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy : The Antiretroviral Therapy Cohort Collaboration ( ARTCC ) (2017) (9)
- Participation in HIV research: the importance of clinic contact factors. (2008) (9)
- Intraperitoneal Administration of Acyclovir in Patients Receiving Continuous Ambulatory Peritoneal Dialysis (1990) (8)
- Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis (2016) (8)
- Increasing HIV subtype diversity in Canadian-born patients living in Southern Alberta, Canada. (2011) (8)
- Timing of Antiretroviral Therapy Initiation and Risk of Cancer among Persons Living with HIV. (2020) (8)
- Panic and agoraphobia: Do treatments targeted for one problem also improve the other? A pilot study. (2005) (8)
- An Emerging Concern—High Rates of Frailty among Middle-aged and Older Individuals Living with HIV (2019) (8)
- Direct-Acting Antiviral Treatment Failure Among Hepatitis C and HIV–Coinfected Patients in Clinical Care (2019) (8)
- Mortality Among Persons Entering HIV Care Compared With the General U.S. Population (2021) (8)
- Understanding the delay in starting antiretroviral therapy despite recent guidelines for HIV patients retained in care (2016) (8)
- Cause‐specific mortality after diagnosis of cancer among HIV‐positive patients: A collaborative analysis of cohort studies (2020) (8)
- Purification and characterization of the reovirus cell attachment protein sigma 1. (1987) (8)
- Antibiotic prescribing in UK care homes 2016–2017: retrospective cohort study of linked data (2020) (8)
- Patient perspectives on de‐simplifying their single‐tablet co‐formulated antiretroviral therapy for societal cost savings (2018) (8)
- Diagnostic uncertainty and urinary tract infection in the emergency department: a cohort study from a UK hospital (2020) (7)
- Zidovudine absorption and small intestinal function in HIV seropositive patients. (1996) (7)
- The Impact of “Churn” on Plasma HIV Burden Within a Population Under Care (2019) (7)
- Viral suppression among persons in HIV care in the United States during 2009-2013: sampling bias in Medical Monitoring Project surveillance estimates. (2019) (7)
- A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohorts (2016) (7)
- Polymyositislike syndromes in acquired immunodeficiency syndrome. (1989) (7)
- Microsporidiosis in AIDS patients. (1993) (7)
- Seroprevalence of cytomegalovirus, Toxoplasma gondii, syphilis, and hepatitis B and C virus infections in a regional population seropositive for HIV infection. (1998) (7)
- Granulomatous Pneumocystis jiroveci pneumonia associated with immune reconstituted HIV. (2008) (7)
- Evaluating medical conferences: the emerging need for a quality metric (2019) (7)
- Herpes simplex virus infection of the hand. Clinical features and management. (1988) (6)
- Improving the timeliness of meticillin-resistant Staphylococcus aureus antimicrobial decolonization therapy administration: a descriptive account☆ (2014) (6)
- Five cases of erroneously diagnosed HIV infection. (1991) (6)
- Canadian Expert Panel recommendations on the management of CNS symptoms related to efavirenz (2001) (6)
- Association of CD4:CD8 With Cause-Specific Mortality in Patients on Long-Term ART (2015) (6)
- Updated direct costs of medical care for HIV‐infected patients within a regional population from 2006 to 2017 (2019) (6)
- LB9. The Effect of Initiating Integrase Inhibitor-based vs. Non-Nucleoside Reverse Transcriptase Inhibitor-based Antiretroviral Therapy on Progression to Diabetes among North American Persons in HIV Care (2019) (6)
- Changes Over Time in Risk of Initial Virological Failure of Combination Antiretroviral Therapy (2017) (6)
- DNA restriction enzyme analysis of digital and genital isolates of herpes simplex virus from three patients. (1988) (5)
- A Case of Long-Term Seronegative Human Immunodeficiency Virus (HIV) Infection: The Importance of the Humoral Response to HIV (2015) (5)
- 10th Conference on Retroviruses and Opportunistic Infections 2003 Boston, USA (2003) (5)
- The Impact of Transfer Patients on the Local Cascade of HIV Care Continuum (2015) (5)
- Interpersonal Violence and Its Impact on Persons Living With HIV: A Social Work Response (2015) (5)
- First occurrence of diabetes, chronic kidney disease, and hypertension among North American HIV-infected adults, 2000-2013. (2016) (5)
- Similar challenges with retention in care issues. (2007) (5)
- Transfer of beta-lactamase plasmids by conjugation in Neisseria gonorrhoeae. (1990) (5)
- Predictors of survival and eradication of Mycobacterium avium complex bacteremia (MAC) in AIDS patients in the Canadian randomized MAC treatment trial. Canadian HIV Trials Network Protocol 010 Study Group. (1999) (5)
- A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection (2017) (5)
- Empyema caused by Clostridium difficile. (1999) (5)
- Impact of three Decades of Antiretroviral Therapy in a Longitudinal Population Cohort Study (2019) (5)
- Gastrointestinal Viral Load and Enteroendocrine Cell Number Are Associated with Altered Survival in HIV-1 Infected Individuals (2013) (5)
- Limitations of opt-out HIV screening and mother-child HIV transmission. (2010) (4)
- Occurrence of Pneumocystis carinii organisms in a peritoneal effusion from a patient with the acquired immunodeficiency syndrome (1991) (4)
- Efavirenz dosing in patients receiving continuous ambulatory peritoneal dialysis. (2000) (4)
- Functional relevance of nonsynonymous mutations in the HIV-1 tat gene within an epidemiologically-linked transmission cohort (2007) (4)
- Infection in AIDS. (1991) (4)
- Cervical cancer epidemiology among HIV-infected women in North America (2010) (4)
- Clinical effectiveness of integrase strand transfer inhibitor-based antiretroviral regimens among adults with human immunodeficiency virus: a collaboration of cohort studies in the United States and Canada. (2020) (4)
- Absence of an association between enteric parasites in the manifestations and pathogenesis of HIV enteropathy in gay men. The GI/HIV Study Group. (1992) (4)
- Healthcare contacts among patients lost to follow-up in HIV care: review of a large regional cohort utilizing electronic health records (2017) (4)
- Lamivudine Reduces Healthcare Resource Use when Added to Zidovudine-Containing Regimens in Patients with HIV Infection (2012) (3)
- Safety profile of soft gelatin formulation of saquinavir in combination with nucleosides in a broad patient population. NV15182 Study Team. (1998) (3)
- HIV diagnosed after 50 years of age (2020) (3)
- The use of antiretroviral agents in patients with renal insufficiency. (1999) (3)
- Projecting the age-distribution of men who have sex with men receiving HIV treatment in the United States (2021) (3)
- Virologic outcomes among adults with HIV using integrase inhibitor-based antiretroviral therapy (2021) (3)
- Long-term HIV/AIDS survivors: Patients living with HIV infection retained in care for over 20 years. What have we learned? (2018) (3)
- An Evaluation of the Cost Effectiveness of Adding Lamivudine to Zidovudine-Containing Regimens in HIV Infection (2012) (3)
- CD4 count at entry into HIV care and at antiretroviral therapy prescription in the US, 2005-2018. (2020) (3)
- Identifying Risk of Viral Failure in Treated HIV-Infected Patients Using Different Measures of Adherence: The Antiretroviral Therapy Cohort Collaboration (2018) (3)
- Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort (2019) (3)
- Asymptomatic neurocognitive impairment is a risk for symptomatic decline in a large HIV Canadian cohort study. (2020) (3)
- Development of risk prediction models to predict urine culture growth for adults with suspected urinary tract infection in the emergency department: protocol for an electronic health record study from a single UK university hospital (2020) (3)
- Using root cause analysis and form redesign to reduce incorrect ordering of HIV tests. (2012) (3)
- Efflux-mediated fluoroquinolone resistance in Streptococcus oralis (2002) (3)
- Construct and Criterion-Related Validity of the Clinical Frailty Scale in Persons With HIV (2021) (3)
- Treatment outcomes with telaprevir-based therapy for HIV/hepatitis C coinfected patients are comparable with hepatitis C monoinfected patients (2015) (3)
- Maintaining the continuity of HIV-care records for patients transferring care between centers: challenges, workloads, needs and risks (2016) (3)
- Economic impact on direct healthcare costs of missing opportunities for diagnosing HIV within healthcare settings (2021) (3)
- Observed CD4 counts at entry into HIV care and at antiretroviral therapy prescription by age in the USA, 2004-18: a cohort study. (2022) (3)
- The relationship between clinical outcomes and empirical antibiotic therapy in patients with community-onset Gram-negative bloodstream infections: a cohort study from a large teaching hospital (2020) (2)
- Factitious AIDS. (1988) (2)
- Editorial commentary: Myocardial infarction in HIV-infected persons: time to focus on the silent elephant in the room? (2015) (2)
- Selection of carbapenem-resistant Pseudomonas aeruginosa in a haematology unit? (2017) (2)
- Postantibiotic effects of three carbapenems on Pseudomonas aeruginosa in the presence of lysine. (1995) (2)
- CD4/CD8 Ratio and Cancer Risk among Adults with HIV. (2022) (2)
- Randomized, double-blind, placebo-controlled, clinic-initiated, Canadian multicenter trial of topical edoxudine 3.0% cream in the treatment of recurrent genital herpes. Canadian Cooperative Study Group. (1991) (2)
- Current and Past Immunodeficiency Are Associated With Higher Hospitalization Rates Among Persons on Virologically Suppressive Antiretroviral Therapy for up to 11 Years. (2021) (2)
- Weight gain post-ART in HIV+ Latinos/as differs in the USA, Haiti, and Latin America (2022) (2)
- Reconstructing SARS-CoV-2 infection dynamics through the phylogenetic inference of unsampled sources of infection (2021) (2)
- Construction and validation of a prognostic model for progression to AIDS or death in drug-naïve patients starting potent antiretroviral therapy. ART Cohort Collaboration (2002) (2)
- Missed opportunities within healthcare for an earlier diagnosis of HIV (2020) (2)
- Guillain-Barré syndrome. (2012) (2)
- The oncology impact of highly active antiretroviral therapy (2007) (2)
- Diffuse Large B-Cell Lymphoma. (2021) (1)
- HIV-related non-Hodgkin's lymphoma in Calgary. (1996) (1)
- Longitudinal evaluation of risk factors and outcomes of blood stream infections due to Staphylococcus species in persons with HIV: An observational cohort study (2020) (1)
- Limited evolution despite years of measurable viremia in a cART-treated seronegative HIV-1 positive individual (2020) (1)
- Long-term consequences of interpersonal violence experiences on treatment engagement and health status in people living with HIV. (2020) (1)
- Chemotherapy Treatment Costs of AIDS-Related Malignancies (1997) (1)
- Predictive variables for peripheral neuropathy in treated HIV-1 infection revealed by machine learning. (2021) (1)
- Parameter estimates for trends and patterns of excess mortality among persons on ART in high-income european settings. (2019) (1)
- HUMAN ORF. AUTHOR'S REPLY (1990) (1)
- Cumulative Viral Load Predicts All-Cause and AIDS-Related Mortality After Initiation of ART (2014) (1)
- Impact of expanded HIV screening. (2007) (1)
- Parameter estimates for trends and patterns of excess mortality among persons on antiretroviral therapy in high-income European settings (2019) (1)
- Use of antibiotics to select auxotrophic mutants of Neisseria meningitidis. (1995) (1)
- Primary lymphoma of the kidney in the acquired immunodeficiency syndrome. (1993) (1)
- Schistosoma and Strongyloides screening in migrants initiating HIV Care in Canada: a cross sectional study (2020) (1)
- Bridging the gap: Educational Theory, Research, and CME Practice HIV Infection Programming as a Case Report (1992) (1)
- Use of blood donation history of people with HIV infection to identify recipients at risk. (1994) (1)
- Central nervous system penetration effectiveness of antiretroviral drugs and neuropsychological impairment in the Ontario HIV Treatment Network Cohort Study (2015) (1)
- CHAPTER 13 – Resistance to Antiviral Agents (1984) (1)
- Susceptibility testing of Neisseria gonorrhoeae to penicillin and spectinomycin in a diagnostic laboratory. (1988) (1)
- The costs of antiretroviral drug wastage. (2000) (1)
- Viral and Host Genetic Factors (2011) (1)
- What are the drivers of high-cost HIV patients? (2021) (1)
- Management of Antimicrobials in Infectious Diseases: Impact of Antibiotic Resistance (2001) (1)
- Characteristics and clinical significance of a stabilization assay to detect specific antibodies to reverse transcriptase of human immunodeficiency virus (1995) (1)
- Costing implications of recent treatment interruption studies. (2006) (1)
- Ethical modifications of the Emergency Drug Release Program for AIDS: a proposal. (1992) (1)
- The prevalence of mental health disorders in people with HIV and the effects on the HIV care continuum (2022) (1)
- Transmission of human immunodeficiency virus (HIV) to a family caregiver through a conjunctival blood splash (2020) (1)
- Grepafloxacin vs Pneumococci Resistant to Fluoroquinolones by a Putative Efflux Mechanism (1999) (1)
- CHAPTER 93 – NEUROLOGICAL DISORDERS ASSOCIATED WITH HUMAN IMMUNODEFICIENCY VIRUS INFECTION (2007) (1)
- Towards Data-Driven Hospital Antimicrobial Stewardship: Secondary use of Routine Electronic Care and Prescribing Records to Inform Antimicrobial Stewardship Programmes (2020) (1)
- Association of Race and Ethnicity With Initial Prescription of Antiretroviral Therapy Among People With HIV in the US. (2023) (1)
- Human fibroblast interferon and acyclovir in cytomegalovirus pneumonia. (1986) (1)
- Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. (2023) (1)
- Molecular Bacteriology: Protocols and Clinical Applications Methods in Molecular Medicine, volume 15: Edited by Neil Woodford and Alan P. Johnson. 1998. ISBN 0-89603-498-4. Humana Press, New Jersey. Pp. 682. $99.50. (1999) (1)
- Mortality for adults entering HIV care under universal early treatment compared to the general US population. (2022) (1)
- CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018 (2020) (1)
- Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years. (2020) (1)
- Current and Past Immunodeficiency are Associated with Higher Hospitalization Rates among Persons on Virologically Suppressive Antiretroviral Therapy for up to Eleven Years. (2020) (1)
- Do contemporary antiretrovirals increase the risk of end-stage liver disease? Signals from patients starting therapy in the NA-ACCORD. (2021) (1)
- CD4 Count at Entry into Care and at Antiretroviral Therapy Prescription among Adults with Human Immunodeficiency Virus in the United States, 2005-2018 (2020) (1)
- Low CD4/CD8 ratio predicts cancer risk among adults with HIV (2021) (1)
- Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study (2022) (1)
- Risk Factors and Outcomes of Bloodstream Infections Among People With Human Immunodeficiency Virus: A Longitudinal Cohort Study From 2000 to 2017 (2022) (0)
- Background: New antiretroviral (ARV) drugs and improved formulations and coformulations of existing ARVs are actively promoted to diminish a patient’s pill burden and to minimise the opportunity for mismatched dosing, (2012) (0)
- Plasma microRNAs are associated with domain-specific cognitive function in people with HIV. (2021) (0)
- Sterne, J. A. C. (2020). Cause-specific mortality after diagnosis of cancer among HIV-positive patients: a collaborative analysis of cohort (2020) (0)
- Optimizing Treatment for Human Immunodeficiency Virus to Improve Clinical Outcomes Using Precision Medicine. (2023) (0)
- Use of the Internet to provide pharmaceutical support in an HIV program (2018) (0)
- FRAILTY IN OLDER ADULTS (>50 YEARS) LIVING WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV). A CARE PROPOSAL (2017) (0)
- Granulocyte-macrophage-colony stimulating factor (1988) (0)
- Evolving trends in causes of death among treated HIV-positive individuals (2015) (0)
- FP29-WE-03 Clinical outcomes and immune effects of antiepileptic drug use in HIV-infected patients (2009) (0)
- 17th International Workshop on HIV Observational Databases, Cavtat, Croatia (2013) (0)
- Lost to follow-up in HIV care: 5-year retrospective review of a large regional cohort in Alberta, Canada (2015) (0)
- A Review of Infections in People Who Use Nonprescription Drugs (2018) (0)
- Transfer ofbeta-lactamase plasmids byconjugation inNeisseria gonorrhoeae (1990) (0)
- Hospitalizations in the ART-CC: 1996-2015 (2017) (0)
- In Defense of Baseline Genotypic Antiretroviral Resistance Testing. (2020) (0)
- Pooch protease paunch (1999) (0)
- CD4:CD8 ratio and CD8 count as prognostic markers for mortality in HIV-positive patients on ART (2017) (0)
- Identification and root-cause analysis of aberrant CD4 counts in an HIV cohort; the importance of quality control in changing laboratory procedure. (2020) (0)
- Machine learning models reveal neurocognitive impairment type and prevalence are associated with distinct variables in HIV/AIDS (2019) (0)
- Mortality declined substantially between 1996-2010 among patients starting ART (2015) (0)
- Protecting the health of children moving to Canada (2019) (0)
- Cases in medical microbiology and infectious diseases:Gilligan, Smiley and Shapiro. 2nd Edition. Book and CD-ROM. Oxford: Blackwell Science, 1998. Price: £62.50. ISBN: 155581106X (1999) (0)
- Association of time-updated adherence to ART on rates of AIDS/death: a cross-cohort analysis (2013) (0)
- 1105 LONG-TERM FOLLOW-UP OF OCCULT HBV QUASISPECIES DIVERSITY AND LYMPHOTROPISM IN HIV-1-INFECTED PATIENTS REACTIVE FOR ANTIBODY TO HBV CORE ANTIGEN (ANTI-HBC) (2011) (0)
- Seroprevalence of HCV infection over four year period in a tertiary health care centre of North India (2015) (0)
- Characteristics and Clinical Significance of a Stabilization Assay To Detect Specific Antibodies to Reverse Transcriptase of Human Immunodeficiency Virus (1995) (0)
- High alcohol use is associated with non-AIDS-related mortality in the ART-CC (2015) (0)
- Corrigendum to: Clinical Effectiveness of Integrase Strand Transfer Inhibitor-Based Antiretroviral Regimens Among Adults With Human Immunodeficiency Virus: A Collaboration of Cohort Studies in the United States and Canada. (2022) (0)
- Seropositivity, Risks, and Morbidity From Varicella-Zoster Virus Infections in an Adult PWH Cohort From 2000–2020 (2022) (0)
- Statins Utilization in Adults With HIV: The Treatment Gap and Predictors of Statin Initiation (2022) (0)
- Longitudinal analysis of HIV outcomes for persons living with HIV in non-urban areas in southern Alberta, Canada. (2021) (0)
- Association of the VACS Index With Hospitalization Among People With HIV in the NA-ACCORD (2021) (0)
- Impact of expanded HIV screening. Authors' reply (2007) (0)
- A Long-term Ecological Study of Two Defined Empirical Antibiotic Regimens in Intensive Care Units (2006) (0)
- The rate of hepatitis C reinfection in Canadians coinfected with HIV and its implications for national elimination. (2023) (0)
- Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada (2022) (0)
- gonorrhoeae.e-deficient mutant of Neisseria Functional characterization of a (2013) (0)
- Verbal Memory Performance and Depressive Symptoms in Persons with Treated HIV. (2023) (0)
- Multi-centre evaluation of HLA-B*5701 allele detection by SSP-PCR typing: a quality assurance initiative (2007) (0)
- Tuberculosis Increases Long-Term Risk of Mortality due to non-AIDS defining events (NADEs) among HIV-infected persons on Antiretroviral Therapy (ART) (2015) (0)
- Effect of adopting the new race-free 2021 CKD-EPI eGFR creatinine equation on racial differences in kidney disease progression among people with HIV; an observational study. (2022) (0)
- Case Presentations in Clinical Infections: I. K. Hosein and M. B. Llewelyn, 1997. ISBN 0-7506-2184-2. Butterworth-Heinemann, Oxford. Pp. 132. £12.00 (paperback). (1997) (0)
- Early antiretroviral therapy not associated with higher cryptococcal meningitis mortality in people with HIV in high-income countries: an international collaborative cohort study. (2023) (0)
- Granulocyte-macrophage colony-stimulating factor (1989) (0)
- Wise Streptococcus pneumoniae Isolates of among Fluoroquinolone-Resistant Clinical Prevalence of a Putative Efflux Mechanism (1998) (0)
- Reduced antiretroviral drug efficacy and concentration in HIV-infected microglia contributes to viral persistence in brain (2017) (0)
- P564 Outcomes of anal HPV screening in HIV+ men who have sex with men attending high resolution anoscopy clinic in canada (2019) (0)
- Colony-Stimulating Factor Granulocyte-MacrophageImmunorestorative Effects of Recruitment, and Cell Structure: Defects in Neutrophil Chemotaxis, HIV and Other Lentiviral Infections Cause (2006) (0)
- Uptake Success and Cost Savings from Switching to a Two-Drug Antiretroviral Regimen. (2021) (0)
- Pneumocystis carinii: A review of an important opportunistic pathogen in AIDS. (1991) (0)
- Distribution of age at death and effects of immunosuppression and ART duration vary according to cause of death in HIV-1 positive people (2012) (0)
- Evaluating medical conferences: the emerging need for a quality metric (2019) (0)
- Comparative Analysis of Mature T-Cell and NK/T-Cell Lymphomas in Patients with and without HIV: Results from the NA-Accord and Complete Cohorts (2021) (0)
- Penicillin permeability in Neisseria gonorrhoeae (1991) (0)
- Supplemental Digital Content (2013) (0)
- Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus Coinfection (2022) (0)
- Viral Breakthrough Episodes Among Persons with HIV in Care in Alberta, Canada: Clinical and Public Health Implications. (2022) (0)
- The changing prevalence of anemia and risk factors in people with HIV in North America who have initiated ART, 2007–2017 (2022) (0)
- Associations of risk group, gender and age with specific causes of death in the ART-CC (2012) (0)
- Associations of Self-reported and Prescription-based Adherence with Viral Suppression in Five HIV Cohort Studies (2013) (0)
- 19th International Workshop on HIV Observation Databases, Catania, Italy (2015) (0)
- Cryptococcal Meningitis and Clinical Outcomes in Persons with HIV: A Global View. (2023) (0)
- Secular Trends in Breast Cancer Risk Among Women With HIV Initiating ART in North America (2021) (0)
- Distinct risks, clinical characteristics and outcomes by age at time of HIV diagnosis. (2020) (0)
- Identifying unidentified recipients of HIV-infected blood. (1998) (0)
- A randomized control trial of high-dose micronutrient-antioxidant supplementation in healthy persons with untreated HIV infection (2022) (0)
- Precautions with BCG preparations in pharmacy (2018) (0)
- Human Orf-Reply (1990) (0)
- Racial, ethnic, and gender disparities in hospitalizations among persons with HIV in the United States and Canada, 2005-2015. (2021) (0)
- Fourth International Workshop . gonorrhoeae : a report of the Serotyping Neisseria (0)
- PO09-MO-10 Neurological disease burden among HIV/AIDS patients receiving active care (2009) (0)
- Empiric neurocognitive performance profile discovery and interpretation in HIV infection (2018) (0)
- FP07-MO-06 HCV core protein potentiates HIV Vpr neurotoxicity by suppressing autophagy (2009) (0)
- 2505. Incidence of Transmitted Drug Resistance and Its Clinical Implications Between 1999 and 2018 in a Regional HIV Population (2019) (0)
- AIDS 2002, Barcelona (2002) (0)
- Initiatives Implemented to Improve the Utilization of Nutrition Services by HIV-Infected Patients Followed at a Regional HIV Centre (2007) (0)
- Defining self-reported and prescription measures of adherence to ART: multi-cohort analysis (2013) (0)
- NOUVEAUTES EN RECHERCHE Gastrointestinal function and structure in HIV-positive patients (2006) (0)
- The changing demographics of women living with HIV/AIDS in southern Alberta from 1982 to 2006. (2012) (0)
- sHIV-1 drug resistance in people on dolutegravir-based ART: Collaborative analysis of cohort studies (2023) (0)
- Transfer of beta-lactamase plasnids by conjugation in Neisseria gonorrhoeae Table 1 Acquisition of the conjugative plasmid by beta-lactamase producing transconjugants Transconjugants (2005) (0)
- Mortality in migrants with HIV in western Europe. (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Michael John Gill?
Michael John Gill is affiliated with the following schools:
